Finance

Lists
DMP:ETR
Dermapharm Holding SE
€33.50
-1.62%
(-0.55) 1D
Nov 19, 5:23:36 PM GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for DMP...
Open
€34.50
High
€34.50
Low
€33.10
Mkt. cap
1.66B
Avg. vol.
21.70K
Volume
30.18K
Dividend
2.63%
Quarterly dividend
€0.22
Ex-dividend date
Jun 29, 2026
P/E ratio
13.37
52-wk high
€51.90
52-wk low
€33.10
EPS
€2.51
Shares outstanding
49.54M
No. of employees
4K
Open
€34.50
High
€34.50
Low
€33.10
Mkt. cap
1.66B
Avg. vol.
21.70K
Volume
30.18K
Dividend
2.63%
Quarterly dividend
€0.22
Ex-dividend date
Jun 29, 2026
P/E ratio
13.37
52-wk high
€51.90
52-wk low
€33.10
EPS
€2.51
Shares outstanding
49.54M
No. of employees
4K
News stories
From web sources and news partners
Profile
Dermapharm Holding SE or Dermapharm AG, based in Grünwald, is a publicly listed German pharmaceutical company specializing in the manufacture and distribution of dermatological and allergological preparations. Wikipedia
About Dermapharm Holding SE
CEOHans-Georg Feldmeier
Employees3.62K
Founded1991
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Last report
Nov 12, 2026
Fiscal period
Q3 2026
- / -
Revenue / Est. (EUR)
343.44M / 305.50M
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
296.46M
305.80M
285.15M
343.44M
Cost of goods sold
113.32M
101.39M
92.31M
97.09M
Cost of revenue
113.32M
101.39M
92.31M
97.09M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
81.14M
78.76M
79.38M
70.81M
Operating expense
100.78M
143.59M
147.60M
159.15M
Total operating expenses
214.11M
244.98M
239.92M
256.23M
Operating income
82.35M
60.83M
45.24M
87.21M
Other non operating income
-13.11M
9.84M
25.81M
-29.62M
EBT including unusual items
46.16M
61.51M
29.95M
39.84M
EBT excluding unusual items
57.48M
61.51M
59.95M
39.84M
Income tax expense
10.01M
16.38M
6.79M
14.84M
Effective tax rate
21.68%
26.63%
22.68%
37.24%
Other operating expenses
209.00K
44.44M
45.10M
57.31M
Net income
36.89M
45.20M
23.22M
25.04M
Net profit margin
12.44%
14.78%
8.14%
7.29%
Earnings per share
0.73
-
-
-
Interest and investment income
-
1.42M
2.01M
-
Interest expense
-11.02M
-10.68M
-12.29M
-17.54M
Net interest expenses
-11.02M
-9.26M
-10.28M
-17.54M
Depreciation and amortization charges
19.43M
20.39M
23.12M
31.02M
EBITDA
89.38M
81.14M
97.45M
119.07M
Gain or loss from assets sale
63.00K
90.00K
31.00K
-92.00K
Upcoming events
AI content may include mistakes. Learn more
Google apps